Skip to main content

Search

Cancer Repair Mechanism Could Be Potential Drug Target
Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Investigational Anti-Clotting Drug Reduces Bleeding Risk Among AF Patients
Few Patients Have Infected Heart Devices Removed Despite Lifesaving Benefits
Racing for ALS Raises Money for Lou Gehrig's Disease Research
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
Duke-UNC Project Wins 3rd Place in American Heart Association Heart Failure Data Challenge
The Duke Transplant Center Performs 10,000th Transplant
Parents and Physicians Team Up to give Tiny Duke Patient a Chance at Recovery from an Extremely Rare Condition.
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
Old-School Health Assessment Beats Genetic Test for Predicting Heart Disease
DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative
Brain Tumor Study Highlights Differences Among Hispanics
What today’s U.S. District Court Abortion Decision Means for Us
Leukemia Drug Shows Potential Against Metastatic HER2-Positive Breast Cancer
Few Digestive Disease Studies Examine Food Insecurity
A Duke Health Statement on Recent Gun Violence
Phase 3 Drug Study Shows Survival Benefit For Some Leukemia Patients
Social Stress Factors Drive Cancer Mechanisms that Help Explain Racial Disparities
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers